Hiroshi Mizuguchi

634 total citations
16 papers, 524 citations indexed

About

Hiroshi Mizuguchi is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Hiroshi Mizuguchi has authored 16 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Oncology. Recurrent topics in Hiroshi Mizuguchi's work include Monoclonal and Polyclonal Antibodies Research (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Hiroshi Mizuguchi is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Hiroshi Mizuguchi collaborates with scholars based in Japan and Spain. Hiroshi Mizuguchi's co-authors include Masahiro Takagi, Hiroshi Kido, Yuki Yamasaki, Shinsuke Fujiwara, Hiroshi Yamada, Dengbing Yao, Junji Chida, Hiroshi Momota, Tetsuya Hashimoto and Hisashi Kitagawa and has published in prestigious journals such as Brain Research, FEBS Letters and Journal of Bacteriology.

In The Last Decade

Hiroshi Mizuguchi

15 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Mizuguchi Japan 9 254 138 129 93 87 16 524
Chad E. Schroeder United States 11 241 0.9× 69 0.5× 76 0.6× 81 0.9× 15 0.2× 20 538
Stefanos A. Kalamidas Greece 14 192 0.8× 317 2.3× 81 0.6× 86 0.9× 63 0.7× 21 592
Hisao Fukushima Japan 9 177 0.7× 65 0.5× 71 0.6× 65 0.7× 47 0.5× 13 432
A C Chou United States 9 202 0.8× 287 2.1× 55 0.4× 28 0.3× 37 0.4× 12 810
Jiho Yoo South Korea 12 374 1.5× 54 0.4× 86 0.7× 13 0.1× 40 0.5× 26 585
T. Kelly Rainbolt United States 9 629 2.5× 135 1.0× 205 1.6× 45 0.5× 23 0.3× 9 819
Haruko Goto Japan 20 727 2.9× 187 1.4× 112 0.9× 129 1.4× 110 1.3× 59 1.0k
M. Roche United States 13 215 0.8× 93 0.7× 55 0.4× 77 0.8× 18 0.2× 23 728
Micol Falabella Italy 12 445 1.8× 51 0.4× 46 0.4× 29 0.3× 29 0.3× 18 668
John C.H. Steele United States 11 183 0.7× 98 0.7× 43 0.3× 65 0.7× 16 0.2× 25 493

Countries citing papers authored by Hiroshi Mizuguchi

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Mizuguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Mizuguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Mizuguchi more than expected).

Fields of papers citing papers by Hiroshi Mizuguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Mizuguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Mizuguchi. The network helps show where Hiroshi Mizuguchi may publish in the future.

Co-authorship network of co-authors of Hiroshi Mizuguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Mizuguchi. A scholar is included among the top collaborators of Hiroshi Mizuguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Mizuguchi. Hiroshi Mizuguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Fujiki, Hiroyuki, Masayuki Furukawa, Tatsuya Yamashita, et al.. (2022). In vitro and in vivo pharmacological profile of OPC-61815, a water-soluble phosphate ester pro-drug of tolvaptan. Journal of Pharmacological Sciences. 150(3). 163–172. 3 indexed citations
2.
Yamada, Yoshihisa, Hiroyuki Fujiki, Hiroshi Mizuguchi, et al.. (2022). Tolvaptan, a vasopressin V<sub>2</sub> receptor antagonist, is the world’s first approved drug for treatment of autosomal dominant polycystic kidney disease (ADPKD). Folia Pharmacologica Japonica. 157(4). 254–260.
3.
Yamada, Yoshihisa, Hiroyuki Fujiki, Hiroshi Mizuguchi, et al.. (2021). Tolvaptan, a vasopressin V<sub>2</sub> receptor antagonist, is the world’s first approved drug for treatment of autosomal dominant polycystic kidney disease (ADPKD). Proceedings for Annual Meeting of The Japanese Pharmacological Society. 94(0). 1–S11. 1 indexed citations
4.
Aihara, Miki, Hiroyuki Fujiki, Hiroshi Mizuguchi, et al.. (2014). Tolvaptan Delays the Onset of End-Stage Renal Disease in a Polycystic Kidney Disease Model by Suppressing Increases in Kidney Volume and Renal Injury. Journal of Pharmacology and Experimental Therapeutics. 349(2). 258–267. 52 indexed citations
5.
Yamasaki, Yuki, et al.. (2012). Protective effects of XBP1 against oxygen and glucose deprivation/reoxygenation injury in rat primary hippocampal neurons. Neuroscience Letters. 518(1). 45–48. 33 indexed citations
7.
Yamasaki, Yuki, Shigeki Nishihara, Hiroshi Mizuguchi, et al.. (2008). Protective effect against Parkinson's disease-related insults through the activation of XBP1. Brain Research. 1257. 16–24. 117 indexed citations
8.
Mizuguchi, Hiroshi, Makoto Ide, Yuichi Kuroda, et al.. (2005). Thermolabile phenotype of carnitine palmitoyltransferase II variations as a predisposing factor for influenza‐associated encephalopathy. FEBS Letters. 579(10). 2040–2044. 77 indexed citations
9.
Nishioka, Motomu, Hiroshi Mizuguchi, Shinsuke Fujiwara, et al.. (2001). Long and accurate PCR with a mixture of KOD DNA polymerase and its exonuclease deficient mutant enzyme. Journal of Biotechnology. 88(2). 141–149. 54 indexed citations
10.
Mizuguchi, Hiroshi, Haruo Mizuno, Kiyoshi Yasukawa, et al.. (2001). Enhanced Signal Transduction by a Directly Fused Protein of Interleukin-6 and Its Receptor.. Journal of Bioscience and Bioengineering. 91(3). 299–304. 2 indexed citations
11.
Mizuguchi, Hiroshi, Haruo Mizuno, Kiyoshi Yasukawa, et al.. (2001). Enhanced signal transduction by a directly fused protein of interleukin-6 and its receptor. Journal of Bioscience and Bioengineering. 91(3). 299–304. 6 indexed citations
12.
Mizuguchi, Hiroshi, et al.. (2000). Screening of an oligopeptide antagonist for interleukin-6 from a random phage library. Biotechnology Letters. 22(12). 1015–1020. 4 indexed citations
13.
Mizuguchi, Hiroshi, et al.. (1999). Characterization and Application to Hot Start PCR of Neutralizing Monoclonal Antibodies against KOD DNA Polymerase. The Journal of Biochemistry. 126(4). 762–768. 45 indexed citations
14.
Tomioka, Kiyoshi, Taro Ishiguro, Hiroshi Mizuguchi, et al.. (1991). Stereoselective reactions. XVII. Absolute structure-cytotoxic activity relationships of steganacin congeners and analogs. Journal of Medicinal Chemistry. 34(1). 54–57. 38 indexed citations
16.
Fujii, Masashi, et al.. (1986). X-ray nondestructive inspection using digital image processing. 15–20. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026